Medios AG (OTCMKTS:MEDOF) Stock Short Interest Report for September

Medios AG (OTCMKTS:MEDOF) was the target of a large increase in short interest in September. As of September 30th, there was short interest totaling 858 shares, an increase of 1,200.0% from the September 15th total of 66 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Medios in a research note on Thursday, August 13th. One investment analyst has rated the stock with a Buy rating. Based on data from MarketBeat.com, the company presently has an average rating of “Buy”.

Medios Stock Performance

OTCMKTS MEDOF remained flat at C$13.64 on Friday. Medios has a 52 week low of C$13.64 and a 52 week high of C$13.64. The stock’s fifty day moving average price is C$13.64 and its 200-day moving average price is C$13.64.

About Medios

Medios AG is a Germany-based specialty pharmaceutical company that supplies medicines and related services for patients with complex, chronic and rare diseases. The company works primarily with pharmacies, medical providers and other healthcare partners, supporting the delivery of therapies that often require specialized handling and coordination.

Its activities include the pharmaceutical supply of specialty medicines and the preparation of patient-specific therapies. Medios focuses on areas such as oncology, autoimmune diseases, neurology and other conditions in which individualized treatment solutions or close pharmaceutical support may be required.

Based in Berlin, Medios serves the German healthcare market through its specialty pharmaceutical platform and pharmacy network.